scientific-skills/treatment-plans/references/regulatory_compliance.md
Treatment plans must comply with multiple federal and state regulations governing healthcare documentation, patient privacy, billing practices, and quality standards. This reference provides comprehensive guidance on regulatory requirements affecting treatment plan development and implementation.
Applicable Rules:
Definition: Any information about health status, provision of healthcare, or payment for healthcare that can be linked to a specific individual.
18 HIPAA Identifiers (Safe Harbor Method):
Safe Harbor Method: Remove all 18 identifiers listed above
Practical De-identification:
Example:
Without Patient Authorization:
With Patient Authorization:
Use, disclose, or request only the minimum amount of PHI necessary to accomplish the purpose.
Exception: Does NOT apply to treatment - providers may share all relevant information for patient care.
Breach: Unauthorized acquisition, access, use, or disclosure of PHI that compromises security or privacy.
Notification Requirements:
Civil Penalties: $100 to $50,000 per violation (up to $1.5 million per year for identical violations)
Criminal Penalties: Up to $250,000 fine and 10 years imprisonment for knowing misuse with intent to sell/transfer PHI
Scope: Federally assisted substance use disorder (SUD) treatment programs
More Restrictive than HIPAA: Provides additional confidentiality protections for SUD treatment records.
Patient Consent Required for most disclosures (even for treatment, payment, operations - differs from HIPAA).
Prohibition on Re-disclosure: Recipients of 42 CFR Part 2-protected information cannot re-disclose without patient consent.
Documentation: Patient consent must be written, specific to the information disclosed, and include expiration date.
Exceptions (Disclosure without consent allowed):
HIPAA Compliance: Covered entities must comply with both HIPAA and 42 CFR Part 2 (whichever is more protective applies).
Note in Treatment Plans: If patient has SUD and received treatment at 42 CFR Part 2 program, annotate: "Substance use information subject to 42 CFR Part 2 confidentiality protections."
Scope: Clinical trials, research involving FDA-regulated products, drug/device manufacturers.
Requirements for Electronic Records and Signatures:
If part of clinical trial: Treatment plans must meet 21 CFR Part 11 requirements for electronic documentation.
Non-Research Clinical Care: Typically NOT subject to 21 CFR Part 11 (HIPAA Security Rule applies instead).
Hospitals, Skilled Nursing Facilities, Home Health Agencies must meet CoPs to receive Medicare/Medicaid reimbursement.
Documentation Requirements:
EHR Requirements (for eligible providers to receive incentive payments):
Medical Necessity: Documentation must support the medical necessity of services billed.
Elements to Document:
E/M Coding Support: Treatment plans support Evaluation and Management (E/M) coding levels:
Used by: Health plans to measure quality
Treatment Plan Elements Supporting HEDIS:
Diabetes:
Cardiovascular:
Preventive Care:
Eligible Clinicians: Medicare Part B providers
Performance Categories:
Treatment Plan Documentation: Supports quality measure reporting (e.g., diabetes HbA1c control, depression screening and follow-up).
Quality Measures: 33+ measures across patient experience, care coordination, preventive health, at-risk populations.
Treatment Plans: Facilitate care coordination, chronic disease management to meet ACO quality benchmarks.
Recommendations:
Treatment Plan Requirements:
Vary by State, common elements:
Prescribers must know state-specific laws.
Purpose: State databases tracking controlled substance prescriptions to identify doctor shopping, overprescribing.
Requirements: Most states require PDMP check before initial opioid prescription and periodically during treatment (e.g., every 3-6 months).
Documentation: Note in treatment plan that PDMP was checked and findings (e.g., "PDMP reviewed, no other controlled substances from other prescribers").
Prescribers: Must operate within scope of practice defined by state law.
Controlled Substances: DEA registration required, state regulations apply.
Definition: Degree of care and skill ordinarily employed by similar practitioners under similar circumstances.
Deviations from Standard: Must be documented with rationale (e.g., patient-specific factors, shared decision-making, evidence supporting alternative approach).
Required for: Procedures, surgeries, medications with significant risks, research.
Elements to Document:
In Treatment Plans: Note informed consent discussion occurred, especially for high-risk treatments (e.g., opioids, chemotherapy, surgery).
Medical Records: State laws vary (typically 7-10 years from last encounter; longer for minors - often until age of majority + statute of limitations).
Electronic Records: Same retention requirements as paper.
Applicable to: Hospitals, ambulatory care, behavioral health, long-term care, laboratories.
Standards Relevant to Treatment Plans:
Patient-Centered Care (PC):
Care Coordination (CC):
Medication Management (MM):
National Patient Safety Goals (NPSG):
Applicable to: Rehabilitation, behavioral health, employment services.
Standards for Treatment Plans:
ICD-10-CM Diagnosis Codes:
CPT Procedure Codes:
Medical Necessity: Treatment must be medically appropriate for diagnosis, meet standard of care, expected to improve condition.
Treatment Plan Link: Plan documents rationale for tests, treatments, referrals → supports medical necessity.
Avoid:
Anti-Kickback Statute: Prohibits offering, paying, soliciting, or receiving remuneration for patient referrals for services reimbursed by federal healthcare programs.
Stark Law: Prohibits physician self-referral for designated health services (DHS) covered by Medicare/Medicaid.
Required Elements:
Documentation: Signed consent form, copy given to participant.
Institutional Review Board reviews and approves research involving human subjects.
Treatment Plans in Research: If part of clinical trial protocol, must be approved by IRB, follow protocol exactly, documented per 21 CFR Part 11.
International Standard for ethical and scientific quality in clinical trials.
Relevant to Treatment Plans: Detailed protocol adherence, documentation of interventions, adverse event reporting.
Tarasoff Rule (varies by state): If patient poses credible threat to identifiable person, provider must:
Documentation: Document threat assessment, steps taken to protect.
Criteria (vary by state): Typically requires patient to be:
Due Process: Emergency hold (24-72 hours), followed by court hearing for longer commitment.
Documentation: Clear documentation of dangerousness, efforts at least restrictive intervention.
Mental Health Parity and Addiction Equity Act (MHPAEA): Health plans must provide mental health/substance use disorder benefits comparable to medical/surgical benefits.
Implications: Cannot limit therapy visits or impose higher copays for mental health vs. medical care.
Document Version: 1.0
Last Updated: January 2025
Next Review: January 2026
Note: Regulations subject to change; verify current requirements.